Spray-on Medications Coming For Animals
by Patricia Collier
Giving a pill to dogs, cats, and other animals will soon become much easier - for both the pill giver and the recipient.
The pharmaceutical giant Eli Lilly has worked out a $9.7 million licensing deal with Acrux, a drug-delivery company, to research and develop spray-on medicines for the animal health care industry.
Melbourne-based Acrux has already developed a spray-on applicator they call a "Metered Dose Transdermal System." The applicator allows a drug to be mixed with enhancers to help the drug absorb into the skin.
Acrux DDS, a subsidiary of Acrux, will work with Eli Lilly’s animal health division to promote the product for the $11 billion worldwide animal health market.
Australian Innovation Minister John Brumby said the technology could change dramatically how drugs were delivered to animals.
"For those of us who have tried to dose stressed, sick pets or farm animals with tablets or injections, this is a real step forward," Brumby said.
Acrux is also developing the transdermal product for use in hormone therapy and for treatment of severe pain, anxiety and depression. The company recently completed a Phase I human study for using the spray with Buspiron, an anti-anxiety medication.
© 2003 Animal News Center, Inc.
Giving a pill to dogs, cats, and other animals will soon become much easier - for both the pill giver and the recipient.
The pharmaceutical giant Eli Lilly has worked out a $9.7 million licensing deal with Acrux, a drug-delivery company, to research and develop spray-on medicines for the animal health care industry.
Melbourne-based Acrux has already developed a spray-on applicator they call a "Metered Dose Transdermal System." The applicator allows a drug to be mixed with enhancers to help the drug absorb into the skin.
Acrux DDS, a subsidiary of Acrux, will work with Eli Lilly’s animal health division to promote the product for the $11 billion worldwide animal health market.
Australian Innovation Minister John Brumby said the technology could change dramatically how drugs were delivered to animals.
"For those of us who have tried to dose stressed, sick pets or farm animals with tablets or injections, this is a real step forward," Brumby said.
Acrux is also developing the transdermal product for use in hormone therapy and for treatment of severe pain, anxiety and depression. The company recently completed a Phase I human study for using the spray with Buspiron, an anti-anxiety medication.
© 2003 Animal News Center, Inc.

Use the feedback form below to submit your comments.

Use the form below to email this article to your friends.

- ON WITH THE SHOW ... "Animals and Paychecks?"
- 28 Mexican Officials Charged in Illegal Hunting Scheme
- Captive Bears In Japan Exploited, Mistreated
- India Government Fails To Prevent Massive Animal Sacrifice
- Welfare Groups Protest Massive Dog Cull in China
- Proposed 'Crocodile Safari Hunts' Spark Outrage
- 'Animal Law' Comes Into Its Own
- Vet Association Updates Stance On Welfare Issues
- Ed Boks Takes Over At NYC Animal Care And Control
- WSPA Launches Animal Welfare Syllabus For Veterinarians
- Fund For Animals Condemns Catskill Park Hunting Plans
- U.S. Animal Protection Groups Form Coalition
- Teaching Compassion For Animals In Saudi Arabia
- Prayers For Hunted Animals
- Dingoes: Great Animals, Terrible Pets
- Icelandic Whalers Harpoon Their First Victims
- UK Conducts Record Number Of Animal Experiments
- Tax Filers to Help Fund Animal Welfare Commission
- Opposition to Farm Animal Confinement Shown
- On With the Show . . . "The Love of Animals"



